SCARDA: Japan’s New Vaccine R&D Center With $1.6bn Budget – But Where's The Goal?
Hopes But Some Concerns
Japan has launched a new center to support vaccine and drug projects as a part of a larger scheme to tackle infectious disease. SCARDA will be in charge of establishing a flagship R&D site for innovative collaborations and controlling funds for R&D projects.
